JPS568315A - Antitumor agent - Google Patents

Antitumor agent

Info

Publication number
JPS568315A
JPS568315A JP8390079A JP8390079A JPS568315A JP S568315 A JPS568315 A JP S568315A JP 8390079 A JP8390079 A JP 8390079A JP 8390079 A JP8390079 A JP 8390079A JP S568315 A JPS568315 A JP S568315A
Authority
JP
Japan
Prior art keywords
compound
agent
formula
active ingredient
single bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8390079A
Other languages
Japanese (ja)
Other versions
JPH0120129B2 (en
Inventor
Koichi Murai
Toshiaki Kobayashi
Katsuo Momoki
Tadashi Ariyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHIN NIPPON RIKA KK
Kaken Pharmaceutical Co Ltd
New Japan Chemical Co Ltd
Original Assignee
SHIN NIPPON RIKA KK
Kaken Pharmaceutical Co Ltd
Kaken Chemical Co Ltd
New Japan Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHIN NIPPON RIKA KK, Kaken Pharmaceutical Co Ltd, Kaken Chemical Co Ltd, New Japan Chemical Co Ltd filed Critical SHIN NIPPON RIKA KK
Priority to JP8390079A priority Critical patent/JPS568315A/en
Priority to GB8021580A priority patent/GB2055576B/en
Priority to DE19803025057 priority patent/DE3025057A1/en
Priority to FR8014836A priority patent/FR2460673A1/en
Publication of JPS568315A publication Critical patent/JPS568315A/en
Publication of JPH0120129B2 publication Critical patent/JPH0120129B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

PURPOSE: An antitumon agent for human beings and animals having low toxicity, having extremely suppressive action on the hypodermic implantation tumor of Ehrlich carcinoma, comprising a benzylidene compound of a polyfunctional alcohol as an active ingredient.
CONSTITUTION: A compound (e.g., 2,4-monobenzylidenesorbitol) shown by the formula I (X1 and X3 are single bond or H; X2 is single bond or H; R is H or alkyl; m is 1W4; n is 1W3) is blended with an organic or inorganic, liquid or solid excipient (e.g., water, getatin, etc.), an auxiliary (e.g., preservative, mois- tening agent, etc.), a clathrate agent (e.g., cyclodextrin, etc.) to give an antitumor agent in the form of pharmaceutical preparation to be administered orally or parenterally. A dose of the active ingredient is 0.5W6,000mg per adult daily. The compound shwon by the formula I is obtained by reacting a compound shown by the formula II (e.g., triose, etc.) with a compound shown by the formula III (e.g., benzaldehyde, etc.).
COPYRIGHT: (C)1981,JPO&Japio
JP8390079A 1979-07-04 1979-07-04 Antitumor agent Granted JPS568315A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP8390079A JPS568315A (en) 1979-07-04 1979-07-04 Antitumor agent
GB8021580A GB2055576B (en) 1979-07-04 1980-07-01 Anti-tumour agent
DE19803025057 DE3025057A1 (en) 1979-07-04 1980-07-02 ANTI-MEDIUM
FR8014836A FR2460673A1 (en) 1979-07-04 1980-07-03 ANTITUMOR AGENTS CONTAINING A CONDENSATION PRODUCT OF SUGAR-DERIVED ALCOHOL AND BENZALDEHYDE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8390079A JPS568315A (en) 1979-07-04 1979-07-04 Antitumor agent

Publications (2)

Publication Number Publication Date
JPS568315A true JPS568315A (en) 1981-01-28
JPH0120129B2 JPH0120129B2 (en) 1989-04-14

Family

ID=13815497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8390079A Granted JPS568315A (en) 1979-07-04 1979-07-04 Antitumor agent

Country Status (4)

Country Link
JP (1) JPS568315A (en)
DE (1) DE3025057A1 (en)
FR (1) FR2460673A1 (en)
GB (1) GB2055576B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000057275A (en) * 1996-11-28 2000-09-15 후지타 기요시 Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them, and gel compositions
DE50213169D1 (en) 2002-08-08 2009-02-12 Chemtura Organometallics Gmbh Process for the preparation and use of mono- and dialkyltin halides
CN111961027B (en) * 2020-08-18 2023-11-17 上海齐润新材料有限公司 Composition and method for preparing transparent articles at low temperature

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2519161A1 (en) * 1975-04-30 1976-11-18 Henkel & Cie Gmbh ANTI-INFLAMMATORS FOR COSMETIC PREPARATIONS

Also Published As

Publication number Publication date
JPH0120129B2 (en) 1989-04-14
FR2460673A1 (en) 1981-01-30
FR2460673B1 (en) 1985-04-19
DE3025057C2 (en) 1990-09-06
GB2055576A (en) 1981-03-11
DE3025057A1 (en) 1981-01-22
GB2055576B (en) 1983-09-14

Similar Documents

Publication Publication Date Title
FR2416012A1 (en) DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
DK568187A (en) TRANSDERMAL FLUX PROCESSING PREPARATION
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
GR3005657T3 (en)
JPS568315A (en) Antitumor agent
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS5661318A (en) Cembranolide diterpen
JPS5746914A (en) Analgesic
IE38967L (en) 16-cyano-pregnene compounds.
JPS55111470A (en) Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS5551018A (en) Carcinostatic agent
JPS56125305A (en) Creamy or milky lotion cosmetic
JPS5675432A (en) Antitumor agent containing ethyl piperidylacetylaminobenzoate
JPS5533459A (en) Remedy for hemorrhoids
JPS57114513A (en) Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative
JPS5675430A (en) Antiarteriosclerotic agent containing ethyl piperidylacetylaminobenzoate
JPS57114514A (en) Antiphlogistic comprising (3-dimethylcarbamoxyphenyl) trimethyl ammonium derivative
JPS57114515A (en) Antipyr eticand analgesic comprising (3-dimethylcarbam- oxyphenyl)trimethyl ammonium derivative
DE3175939D1 (en) Use of gamma-piperidino-butyrophenones for the preparation of medicaments for treating diarrhoea
JPS5545658A (en) Carcinostatic agent
JPS579722A (en) Immunologically active substance and its preparation
JPS643120A (en) Drug composition having inhibitory action on encephalopathy
GB1091134A (en) Pharmaceutical and veterinary compositions comprising a sorbitol acetal